Evidence map›Paper›PMID 40445002›Full record

ArticleBriefings in bioinformatics2025

Integrated multimodal hierarchical fusion and meta-learning for enhanced molecular property prediction.

Xianjun Han, Zhenglong Zhang, Can Bai, Zijian Wu

Abstract read
In one paragraph

Article in Briefings in bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Xianjun HanSchool of Computer Science and Technology, Anhui University, Jiulong Road 111, Hefei 230601, China.
Zhenglong ZhangSchool of Computer Science and Technology, Anhui University, Jiulong Road 111, Hefei 230601, China.
Can BaiSchool of Acupuncture and Tuina, Anhui University of Chinese Medicine, Longzihu Road 350, Hefei 230012, China.
Zijian WuSchool of Acupuncture and Tuina, Anhui University of Chinese Medicine, Longzihu Road 350, Hefei 230012, China.

Funding

Natural Science Research Project of Anhui Educational Committee RZ2300001813
6 · The paper itself

Abstract

Accurately predicting the pharmacological and toxicological properties of molecules is a critical step in the drug development process. Owing to the heterogeneity of molecular property prediction tasks, most of the current methods rely on building a base model and fine-tuning it to address specific properties. However, constructing a high-quality base model is a time-consuming procedure and requires a carefully designed network architecture; in addition, in certain rare molecular property prediction tasks, the base model often does not transfer well to new tasks. In this work, we adopt a meta-learning-based training framework that enables our model to adapt to diverse tasks with limited data, thereby preventing data scarcity from impacting certain molecular property predictions. Additionally, this framework leverages the correlations between different tasks, allowing the constructed model to quickly adapt to new prediction tasks. Moreover, we propose a multimodal fusion framework that combines two-dimensional molecular graphs with molecular images. In the molecular graphs, node-, motif-, and graph-level features are hierarchically guided from low to high levels, fully exploiting the molecular representation and more efficiently conducting hierarchical fusion. Experimental results indicate that our model outperforms the baseline models across various performance indicators, thereby validating the effectiveness of our approach.

Indexed as

Computational BiologyMachine LearningAlgorithmsmeta-learning algorithmmolecular graphmolecular property predictionmultimodal fusion

Identifiers

PMID40445002
PMCPMC12123521

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.